FT

Frederic Triebel

IR Institut Gustave Roussy: 10 patents #3 of 201Top 2%
IS Immutep S.A.S.: 10 patents #1 of 9Top 15%
AN Applied Research Systems Ars Holding N.V.: 7 patents #3 of 219Top 2%
RU Roussel Uclaf: 4 patents #105 of 430Top 25%
NA Novartis Ag: 3 patents #1,476 of 5,128Top 30%
AS Aventis Pharma S.A.: 3 patents #139 of 591Top 25%
HR Hoechst Marion Roussel: 1 patents #151 of 309Top 50%
Overall (All Time): #104,691 of 4,157,543Top 3%
33
Patents All Time

Issued Patents All Time

Showing 25 most recent of 33 patents

Patent #TitleCo-InventorsDate
12252535 Antibody molecules to LAG-3 and uses thereof Chrystelle Brignone, Walter A. Blattler, Jennifer Marie Mataraza, Catherine Anne Sabatos-Peyton, Hwai Wen Chang +1 more 2025-03-18
12214012 Combined preparations for the treatment of cancer 2025-02-04
11684654 Combined preparations for the treatment of cancer or infection Chrystelle Brignone 2023-06-27
11680104 Anti-LAG-3 antibodies Chrystelle Brignone 2023-06-20
11583582 Use of recombinant LAG-3 or the derivatives thereof for eliciting monocyte immune response 2023-02-21
10940181 Combined preparations for the treatment of cancer or infection Chrystelle Brignone 2021-03-09
10874713 Combined preparations for the treatment of cancer or infection Chrystelle Brignone 2020-12-29
10736940 Combined preparations for the treatment of cancer 2020-08-11
10711060 Antibody molecules to LAG-3 and uses thereof Chrystelle Brignone, Walter A. Blattler, Jennifer Marie Mataraza, Catherine Anne Sabatos-Peyton, Hwai Wen Chang +1 more 2020-07-14
10232038 Use of recombinant LAG-3 or the derivatives thereof for eliciting monocyte immune response 2019-03-19
9908936 Antibody molecules to LAG-3 and uses thereof Chrystelle Brignone, Walter A. Blattler, Jennifer Marie Mataraza, Catherine Anne Sabatos-Peyton, Hwai Wen Chang +1 more 2018-03-06
9579382 Use of recombinant LAG-3 or the derivatives thereof for eliciting monocyte immune response 2017-02-28
9244059 Cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease Bernard Vanhove, Thomas HAUDEBOURG 2016-01-26
8709426 Nucleotide sequence coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses Thierry Hercend, Sergio Roman-Roman, Laurent Ferradini 2014-04-29
8425897 Compositions containing LAG-3 and cells that secrete GM-CSF and methods of use Karin Jooss, Betty Chan Li 2013-04-23
7294712 Nucleotide sequences coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses Thierry Hercend, Sergio Roman-Roman, Laurent Ferradini 2007-11-13
7109026 Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment 2006-09-19
6875844 Peptide compounds derived from a shifted ORF of the iCE gene Christophe Ronsin, Véronique Scott 2005-04-05
6855802 Mutated peptide compounds, derived from hsp70, useful in cancer immunotherapy Catherine Gaudin 2005-02-15
RE38313 Soluble polypeptide fractions of the LAG-3 protein, production method, therapeutic composition, anti-idiotype antibodies Florence Faure, Thierry Hercend, Bertrand Huard 2003-11-11
6596536 Nucleotide sequences coding for variable regions of the alpha chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses Thierry Hercend, Sergio Roman-Roman, Laurent Ferradini 2003-07-22
6482925 Mutants of the LAG-3 proteins and nucleotides encoding LAG-3 mutants Nabil El Tayar, Bertrand Huard, Renato Mastrangeli 2002-11-19
6410509 Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment 2002-06-25
6143273 Therapeutic composition containing antibodies to soluble polypeptide fractions of LAG-3 protein Florence Faure, Thierry Hercend, Bertrand Huard 2000-11-07
6114516 Nucleotide sequences coding for variable regions of the .alpha.chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic muses Thierry Hercend, Sergio Roman-Roman, Laurent Ferradini 2000-09-05